Is excessive daytime sleepiness a separate manifestation in Parkinson's disease?

Acta Neurologica Scandinavica

Volumn 132, Issue 2, 2015, Pages 97-104

  Hoglund A ^a,b   Broman, J E ^c   Palhagen S ^a,b   Fredrikson, S ^a,b   Hagell, P ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d KRISTIANSTAD UNIVERSITY   (Sweden)

Author keywords

Disorders of excessive somnolence; Factor analysis; Parkinson's disease; Regression analysis; Symptom assessment

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; APOMORPHINE; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PRAMIPEXOLE; SELEGILINE;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAYTIME SOMNOLENCE; DEPRESSION; EPWORTH SLEEPINESS SCALE; EXCESSIVE DAYTIME SLEEPINESS; FEMALE; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY FATIGUE SCALE; FUNCTIONAL STATUS ASSESSMENT; GAIT DISORDER; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; NOTTINGHAM HEALTH PROFILE; PAIN; PARKINSON DISEASE; PITTSBURGH SLEEP QUALITY INDEX; RATING SCALE; SELF REPORT; STANDING; SUBTHALAMIC NUCLEUS; SYMPTOM; AGED; COMPLICATION; DISORDERS OF EXCESSIVE SOMNOLENCE; REGRESSION ANALYSIS;

AGED; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; REGRESSION ANALYSIS;

EID: 84935698029     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12378     Document Type: Article

References (36)

1. Videnovic A, Golombek D. Circadian and sleep disorders in Parkinson's disease. Exp Neurol 2013;243:45-56.
2. MEDICINE. American Academy of Sleep Medicine. International classification of sleep disorders, 2ed: diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine, 2005.
3. Happe S. Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management. Drugs 2003;63:2725-37.
4. Johns MW. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res 2000;9:5-11.
5. O'suilleabhain PE, Dewey RB Jr. Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Arch Neurol 2002;59:986-9.
6. Borek LL, Amick MM, Friedman JH. Non-motor aspects of Parkinson's disease. CNS Spectr 2006;11:541-54.
7. Breen DP, Williams-Gray CH, Mason SL, Foltynie T, Barker RA. Excessive daytime sleepiness and its risk factors in incident Parkinson's disease. J Neurol Neurosurg Psychiatry 2013;84:233-4.
8. Gjerstad MD, Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology 2006;67:853-8.
9. Goldman JG, Ghode RA, Ouyang B, Bernard B, Goetz CG, Stebbins GT. Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease. Parkinsonism Relat Disord 2013;19:806-11.
10. Kurtis MM, Rodriguez-Blazquez C, Martinez-Martin P, on behalf of the ELEP Group. Relationship between sleep disorders and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2013;19:1152-55.
11. Verbaan D, van Rooden SM, Visser M, Marinus J, van Hilten JJ. Nighttime sleep problems and daytime sleepiness in Parkinson's disease. Mov Disord 2008;23:35-41.
12. Boddy F, Rowan EN, Lett D, O'brien JT, McKeith IG, Burn DJ. Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2007;22:529-35.
13. van Rooden SM, Visser M, Verbaan D, Marinus J, van Hilten JJ. Patterns of motor and non-motor features in Parkinson's disease. J Neurol Neurosurg Psychiatry 2009;80:846-50.
14. Hagell P, Hoglund A, Reimer J, et al. Measuring fatigue in Parkinson's disease: a psychometric study of two brief generic fatigue questionnaires. J Pain Symptom Manage 2006;32:420-32.
15. Goetz CG, Stebbins GT, Chmura TA, Fahn S, Klawans HL, Marsden CD. Teaching tape for the motor section of the unified Parkinson's disease rating scale. Mov Disord 1995;10:263-6.
16. Klawans HL, Goetz CG, Tanner CM. Common movement disorders: a video presentation. Philadelphia, PA: Lippincott Williams & Wilkins, 1988.
17. Hagell P, Broman JE. Measurement properties and hierarchical item structure of the Epworth Sleepiness Scale in Parkinson's disease. J Sleep Res 2007;16:102-9.
18. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
19. Marinus J, Visser M, van Hilten JJ, Lammers GJ, Stiggelbout AM. Assessment of sleep and sleepiness in Parkinson disease. Sleep 2003;26:1049-54.
20. Marinus J, Leentjens AF, Visser M, Stiggelbout AM, van Hilten JJ. Evaluation of the hospital anxiety and depression scale in patients with Parkinson's disease. Clin Neuropharmacol 2002;25:318-24.
21. Hagell P, Whalley D, McKenna SP, Lindvall O. Health status measurement in Parkinson's disease: validity of the PDQ-39 and Nottingham Health Profile. Mov Disord 2003;18:773-83.
22. Stebbins GT, Goetz CG. Factor structure of the Unified Parkinson's Disease Rating Scale: motor examination section. Mov Disord 1998;13:633-6.
23. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-53.
24. Carroll J. The nature of the data, or how to choose a correlation coefficent. Psychometrika 1961;26:347-72.
25. Wasner G, Deuschl G. Pains in Parkinson disease-many syndromes under one umbrella. Nat Rev Neurol 2012;8:284-94.
26. Borek LL, Kohn R, Friedman JH. Mood and sleep in Parkinson's disease. J Clin Psychiatry 2006;67:958-63.
27. Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol 2001;58:1611-5.
28. Dissanayaka NN, Sellbach A, Silburn PA, O'sullivan JD, Marsh R, Mellick GD. Factors associated with depression in Parkinson's disease. J Affect Disord 2011;132:82-8.
29. Vingerhoets FJ, Schulzer M, Calne DB, Snow BJ. Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? Ann Neurol 1997;41:58-64.
30. Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord 2006;21:1123-30.
31. Gjerstad MD, Aarsland D, Larsen JP. Development of daytime somnolence over time in Parkinson's disease. Neurology 2002;58:1544-6.
32. Kato S, Watanabe H, Senda J, et al. Widespread cortical and subcortical brain atrophy in Parkinson's disease with excessive daytime sleepiness. J Neurol 2012;259:318-26.
33. Jaussent I, Bouyer J, Ancelin ML, et al. Excessive sleepiness is predictive of cognitive decline in the elderly. Sleep 2012;35:1201-7.
34. Arnulf I. Excessive daytime sleepiness in parkinsonism. Sleep Med Rev 2005;9:185-200.
35. Zibetti M, Rizzone M, Merola A, et al. Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease. Acta Neurol Scand 2013;127:e28-32.
36. Norman GR, Steiner DL. Biostatistics - The bare essentials. Hamilton: B.C. Decker, Inc., 2008.